Lombard Medical has named Kurt Lemvigh as CEO. Mr. Lemvigh is a veteran medical device executive with more than 30 years of experience. He currently resides in the U.K. and has held senior sales, marketing and operational positions at various public and private companies including Spacelabs, Cardiac Science, GE and Marquette-Hellige.
Proclara Biosciences has appointed Suzanne Bruhn, Ph.D., as chief executive officer. Dr. Bruhn most recently served as president and CEO of Promedior. Previously, she was senior vice president of strategic planning and program management at Shire’s Human Genetic Therapies division. She serves on the boards of Aeglea BioTherapeutics and Pliant Therapeutics.
Pulmatrix has appointed Ted Raad, as chief business officer. Most recently, he served as chief commercial officer at Option Care. Prior to that, he was a business unit head at Sunovion.